SEC Form D · filed March 5, 2018
Finch Therapeutics Group, Inc
Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.
People & firms on this filing (27)
Carter G. Mcnabb · Louisville, CODirectorJames Burgess · Somerville, MADirectorChris Lange · Somerville, MADirectorMatthew N. Whitehead · Hong Kong, Hong KongExec · DirectorMichael Galgon · Seattle, WADirectorAlexander T. Edwards · Boston, MAExecZain Kassam · Somerville, MAExecR. J. Price · Somerville, MADirectorAndrew Mulderry · Somerville, MADirectorKerry Song · San Clemente, CAExecJackie N. Charlesworth · Hong Kong, Hong KongDirectorPatrick Dunn · PROVIDENCE, RIExecMarc N. Puglia · PROVIDENCE, RIDirectorJeffery A. Smisek · Somervlle, MADirectorAllison Harr · Seattle, WADirectorBracken T. Darrell · Boston, MAExec · DirectorAndrew Noh · Somerville, MADirectorBenjamin Enerson · Somerville, MAExecMark Smith · Somerville, MAExec · DirectorHarry W. Lengsfield · NEW YORK, NYExecMilton Berlinski · New York, NYDirectorTao R. Wang · Newtown Square, PADirectorTodd Haskins · New York, NYDirectorPeter Aberg · New York, NYDirectorDavid T. Sinclair · Boston, MADirectorTimothy H. Baynes · Strafford, MODirectorLair G. Kennedy · Louisville, CODirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗